In the present study, CKD mice had a significantly higher degree of renal hypoxia than control mice, and HIF-2α activation at a later stage of CKD mitigated renal hypoxia and abrogated renal dysfunction as well as the progression of fibrosis. The gene discussed is EPAS1; the disease is chronic kidney disease.